BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14677037)

  • 1. Churg-Strauss syndrome (CSS) in a patient receiving pranlukast.
    Kobayashi S; Ishizuka S; Tamura N; Takaya M; Kaneda K; Hashimoto H
    Clin Rheumatol; 2003 Dec; 22(6):491-2. PubMed ID: 14677037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Churg-Strauss syndrome and the leukotriene receptor antagonist pranlukast.
    Shimbo J; Onodera O; Tanaka K; Tsuji S
    Clin Rheumatol; 2005 Nov; 24(6):661-2. PubMed ID: 15578247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?
    Wechsler ME; Pauwels R; Drazen JM
    Drug Saf; 1999 Oct; 21(4):241-51. PubMed ID: 10514017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Churg-Strauss syndrome after reduction of inhaled corticosteroid in a patient treated with pranlukast for asthma.
    Hashimoto M; Fujishima T; Tanaka H; Kon H; Saikai T; Suzuki A; Nakatsugawa M; Abe S
    Intern Med; 2001 May; 40(5):432-4. PubMed ID: 11393418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma.
    Wechsler ME; Finn D; Gunawardena D; Westlake R; Barker A; Haranath SP; Pauwels RA; Kips JC; Drazen JM
    Chest; 2000 Mar; 117(3):708-13. PubMed ID: 10712995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antileukotrienes and Churg-Strauss syndrome].
    Guilpain P; Pagnoux C; Lhote F; Mouthon L; Guillevin L
    Presse Med; 2007 May; 36(5 Pt 2):890-4. PubMed ID: 17383148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Churg-Strauss syndrome during corticosteroid tapering in a patient with bronchial asthma receiving pranlukast].
    Baba K; Niwa S; Yagi T; Sakakibara A; Kobayashi T; Matsumoto Y
    Arerugi; 2000 Jun; 49(6):512-5. PubMed ID: 10916890
    [No Abstract]   [Full Text] [Related]  

  • 8. Churg Strauss syndrome after introducing oral steroid to inhaler: a report of three cases.
    Fallah-Tafti S; Mansouri D; Masjedi MR; Marashian M; Faridian D
    Iran J Allergy Asthma Immunol; 2006 Jun; 5(2):89-94. PubMed ID: 17237583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum interleukin-5 levels correlate with disease activity of Churg-Strauss syndrome in a patient treated with a leucotriene receptor antagonist, pranlukast, and inhaled corticosteroid.
    Taki H; Shinoda K; Hounoki H; Ogawa R; Ishizawa S; Sugiyama E; Tobe K
    Scand J Rheumatol; 2010 Aug; 39(4):341-3. PubMed ID: 20560805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast.
    Kinoshita M; Shiraishi T; Koga T; Ayabe M; Rikimaru T; Oizumi K
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):534-5. PubMed ID: 10069892
    [No Abstract]   [Full Text] [Related]  

  • 11. [The influence of leukotriene receptor antagonists treatment on Churg-Strauss syndrome].
    Szczeklik W; Sokołowska BM; Mastalerz L; Górka J; Pacułt K; Soja J; Musiał J
    Przegl Lek; 2010; 67(7):439-42. PubMed ID: 21387750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Churg-strauss syndrome in patients treated with omalizumab.
    Wechsler ME; Wong DA; Miller MK; Lawrence-Miyasaki L
    Chest; 2009 Aug; 136(2):507-518. PubMed ID: 19411292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Churg-Strauss syndrome after pranlukast treatment in a patient not receiving corticosteroids.
    Katsura T; Yoshida F; Takinishi Y
    Ann Intern Med; 2003 Sep; 139(5 Pt 1):386-7. PubMed ID: 12965953
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukotriene antagonists and the Churg-Strauss syndrome.
    Jamaleddine G; Diab K; Tabbarah Z; Tawil A; Arayssi T
    Semin Arthritis Rheum; 2002 Feb; 31(4):218-27. PubMed ID: 11836655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Churg-Strauss syndrome with severe multiple mononeuropathy after leukotriene receptor antagonist treatment in one of the monozygotic twins with asthma: case report.
    Targońska-Stepniak B; Majdan M; Haberek G; Papuć E; Wnukowska K
    Pol Arch Med Wewn; 2009 Nov; 119(11):761-4. PubMed ID: 19920803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma drug use and the development of Churg-Strauss syndrome (CSS).
    Harrold LR; Patterson MK; Andrade SE; Dube T; Go AS; Buist AS; Chan KA; Weller PF; Wechsler ME; Yood RA; Davis KJ; Platt R; Walker AM
    Pharmacoepidemiol Drug Saf; 2007 Jun; 16(6):620-6. PubMed ID: 17192840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database.
    Bibby S; Healy B; Steele R; Kumareswaran K; Nelson H; Beasley R
    Thorax; 2010 Feb; 65(2):132-8. PubMed ID: 20147592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Churg-Strauss and montelukast.
    Carlesimo M; Mari E; Palese E; Pranteda G; Camplone G
    Int J Immunopathol Pharmacol; 2011; 24(4):1079-82. PubMed ID: 22230414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful multidrug treatment of a pediatric patient with severe Churg-Strauss syndrome refractory to prednisolone.
    Watanabe S; Aizawa-Yashiro T; Tsuruga K; Takahashi T; Ito E; Tanaka H
    Tohoku J Exp Med; 2011 Oct; 225(2):117-21. PubMed ID: 21914976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Churg-Strauss syndrome in two patients receiving montelukast.
    Guilpain P; Viallard JF; Lagarde P; Cohen P; Kambouchner M; Pellegrin JL; Guillevin L
    Rheumatology (Oxford); 2002 May; 41(5):535-9. PubMed ID: 12011377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.